CLNN Projected Dividend Yield
Clene Inc ( NASDAQ : CLNN )Clene is a clinical-stage pharmaceutical company focusing on the discovery, development, and commercialization of clean-surfaced nanotechnology therapeutics. Co. is focused on addressing the unmet medical needs in two areas: first, those related to central nervous system disorders including Amyotrophic Lateral Sclerosis, Multiple Sclerosis, and Parkinson's Disease; and second, those related to COVID-19, an infectious viral respiratory disease with serious and sometimes fatal co-morbidities. In addition to the development of clean-surfaced nanocrystals, Co.'s electro-crystal-chemistry platform can produce ionic solutions of various transition elements including silver, zinc, and others. 20 YEAR PERFORMANCE RESULTS |
CLNN Dividend History Detail CLNN Dividend News CLNN Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |